Coculture of clones from HLT and CRC was used to assess molecular changes.<h4>Results</h4>We found that the morphological characteristics, clonogenic ability, and differentiation ability of NAT-derived clones were consistent with those of HLT-derived clones. The gene discussed is BRD2; the disease is colorectal carcinoma.